The latest closing stock price for Blueprint Medicines as of November 08, 2024 is 100.83.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,343 today, roughly 4 times their original investment - a 18.24% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 20.9% above the current share price.
The Blueprint Medicines 52-week low stock price is 56.74, which is 43.7% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 91.99.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,343 today, roughly 4 times their original investment - a 18.24% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 20.9% above the current share price.
The Blueprint Medicines 52-week low stock price is 56.74, which is 43.7% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 91.99.